|
Volumn 47, Issue 6, 2004, Pages 976-977
|
Response to Chiasson et al.: Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: Facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACARBOSE;
PLACEBO;
ANGINA PECTORIS;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
DATA ANALYSIS;
FOLLOW UP;
HEART INFARCTION;
HEART MUSCLE REVASCULARIZATION;
HUMAN;
HYPERTENSION;
IMPAIRED GLUCOSE TOLERANCE;
INTERNET;
METHODOLOGY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NOTE;
PERIPHERAL VASCULAR DISEASE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROPHYLAXIS;
PUBLICATION;
RANDOMIZATION;
RISK ASSESSMENT;
SIDE EFFECT;
|
EID: 3142746834
PISSN: 0012186X
EISSN: None
Source Type: Journal
DOI: 10.1007/s00125-004-1410-y Document Type: Note |
Times cited : (13)
|
References (8)
|